New hope for patients with cancer-induced bone diseases

Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.

Srinivasa Rao Rao

MBBS, MS (res), DPhil, AFHEA Srinivasa Rao Rao - Senior Researcher in Cancer Genomics

Chen-Yi Wang

Chen-Yi Wang - Senior Research Associate

Irina Udalova

Irina Udalova - Professor of Molecular Immunology

Lina Akinyi

Lina Akinyi - DPhil student

Ed Wheeler

Ed Wheeler - DPhil student

Amy O’Connor

Amy O’Connor - DPhil student

Akira Wiberg

BA BM BCh DPhil FRCS(Plast) Akira Wiberg - Senior Clinical Research Fellow

Wesley Tung

Wesley Tung - DPhil student

Nianna Kjelstrup-Osorio

Nianna Kjelstrup-Osorio - DPhil student

Juan Espitia Jaramillo

Juan Espitia Jaramillo - DPhil student

Alexander Maslaris

Alexander Maslaris - Senior Clinical Research Fellow

Charlotte Bell

Charlotte Bell - Program Director – Industry Liaison in Experimental Medicine

Anil Prabhu

Anil Prabhu - Clinical Research Fellow in Gastroenterology

Maria Navarro Perez

Maria Navarro Perez - Postdoctoral Research Assistant

Kady Jones

Kady Jones - Research Assistant

Kaden Blakey

Kaden Blakey - OCTRU Medical Statistician

Nick Foster

Nick Foster - Senior IT Analyst

Pak Hnag (Patrick) Wan

Pak Hnag (Patrick) Wan - Data Collection and Processing Assistant

Ioana Marian

MSc Ioana Marian - OCTRU Senior Medical Statistician

Gary Collins

PhD Gary Collins - Honorary departmental professor

Search results

Found 31107 matches for